Global maker of generics, APIs, biosimilars and OTC medicines
Dr. Reddy's is a Hyderabad-based pharmaceutical manufacturer running a dual stack: plant-floor control systems (SCADA, DCS, HMI, LIMS) alongside SAP S/4HANA, Kinaxis RapidResponse and MuleSoft for planning and integration. Hiring is accelerating and sales-led, and job-post pain points cluster around inventory planning, product availability and pricing, pointing to supply-chain and commercial optimization as near-term priorities.
Notable leadership hires: Engineering Lead
Dr. Reddy's Laboratories is a public pharmaceutical company founded in 1984 and headquartered in Hyderabad, India, with more than 10,000 employees. Its portfolio spans active pharmaceutical ingredients, generics, branded generics, biosimilars and over-the-counter products. The company sells across markets including the USA, India, Russia and CIS countries, China, Brazil and Europe. Current hiring spans the United States, South Africa, India, Colombia, Malaysia and Germany, covering sales, engineering, manufacturing, marketing, operations and research functions.
Dr. Reddy's uses SAP S/4HANA, Kinaxis RapidResponse, Salesforce, Veeva, MuleSoft Anypoint, AWS and IQVIA, plus manufacturing and lab systems such as SCADA, DCS, LIMS, HPLC and LC-MS/MS.
Dr. Reddy's is hiring in the United States, South Africa, India, Colombia, Malaysia and Germany, with sales the most active function and hiring velocity accelerating.
Job posts point to a new OTC product launch, biologic brand launch pricing strategy, digital initiatives, omni-channel promotion and QbD-based process optimization.
Other companies in the same industry, closest in size
Dr. Reddy's Laboratories's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.